National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
Quick Links
Director's Corner
Updates from the Director

Dictionary of Cancer Terms
Cancer-related terms

NCI Drug Dictionary
Definitions, names, and links

Funding Opportunities
Research and training

NCI Publications
Order/download free booklets

Advisory Boards and Groups
Information, meetings, reports

Science Serving People
Learn more about NCI

Español
Información en español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

NCI Responds to Hurricanes

The Nation's Investment in Cancer Research FY 2009

Cancer Trends Progress Report: 2007 Update

Past Highlights
You CAN Quit Smoking Now!
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant fowlpox-CEA(6D)/TRICOM vaccine
A cancer vaccine comprised of a recombinant fowlpox virus vector encoding the carcinoembryonic antigen (CEA) and a TRIad of COstimulatory Molecules (B7-1, ICAM-1 and LFA-3) (TRICOM). This agent may enhance CEA presentation to antigen presenting cells (APC) and activate cytotoxic T-cells against CEA-expressing tumors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:fowlpox-CEA-B7-1/ICAM-1/LFA-3
rF-CEA(6D)TRICOM



Previous:recombinant CD40-ligand, recombinant dHER2 vaccine, recombinant flt3 ligand, recombinant fowlpox GM-CSF vaccine adjuvant, recombinant fowlpox-B7.1 vaccine
Next:recombinant fowlpox-prostate apecific antigen vaccine, recombinant fowlpox-TRICOM vaccine, recombinant fowlpox-tyrosinase vaccine, recombinant human 6Ckine, recombinant human chorionic gonadotropin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov